{"symbol": "GTHX", "companyName": "G1 Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.g1therapeutics.com", "description": "G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It engages in developing novel, small-molecule therapies to target significant unmet needs to treat cancer.", "CEO": "Mark A. Velleca", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}